Literature DB >> 11026170

Severe leukopenia with valproate.

D D Storch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11026170     DOI： 10.1097/00004583-200010000-00003

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN： 0890-8567            Impact factor:   8.829


× No keyword cloud information.
  3 in total

1.  Neutropenia and Leukopenia After Cross Taper From Quetiapine to Divalproex for the Treatment of Borderline Personality Disorder.

Authors:  Caroline Richmond; Stephanie Coveart
Journal:  Fed Pract       Date:  2022-04-11

Review 2.  Dispensability of Annual Laboratory Follow-Up After More than 2 Years of Valproic Acid Use: A Systematic Review.

Authors:  Rosanne W Meijboom; Koen P Grootens
Journal:  CNS Drugs       Date:  2017-11       Impact factor: 5.749

3.  Novel use of granulocyte colony stimulating factor as an adjunct for treatment of schizoaffective disorder complicated by sodium valproate induced agranulocytosis.

Authors:  S Subbarayan; S Thomas; M George
Journal:  Indian J Psychiatry       Date:  2012-07       Impact factor: 1.759
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.